HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment.

Abstract
Twenty symptomatic patients without erosive esophagitis underwent 24-h esophageal pH monitoring after failing standard medical antireflux treatment. Sixty-five percent had abnormal esophageal acid exposure, and the majority of these improved on proton pump inhibitor therapy. However, 35% had a normal 24-h pH test. One patient had coronary artery disease, one had diffuse esophageal spasm, and two had a negative work-up and no improvement with omeprazole. Consequently, we suggest that patients like these have an omeprazole trial. If symptoms persist, 24-h esophageal pH monitoring can appropriately define more rational management. Patients with abnormal esophageal acid exposure will require more aggressive acid-control therapy, whereas those with normal esophageal acid exposure will need further work-up to assess the cause of their symptoms.
AuthorsR Fass, C Mackel, R E Sampliner
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 19 Issue 2 Pg. 97-9 (Sep 1994) ISSN: 0192-0790 [Print] United States
PMID7963375 (Publication Type: Journal Article)
Chemical References
  • Anti-Ulcer Agents
  • Proton Pump Inhibitors
  • Omeprazole
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Ulcer Agents (therapeutic use)
  • Esophagitis
  • Esophagus (metabolism)
  • Female
  • Gastroesophageal Reflux (drug therapy, physiopathology)
  • Humans
  • Hydrogen-Ion Concentration
  • Male
  • Middle Aged
  • Monitoring, Ambulatory
  • Omeprazole (therapeutic use)
  • Prospective Studies
  • Proton Pump Inhibitors
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: